Japan medicine information and human support for international patients.
Japan
Ozempic Japan information page
Ozempic in Japan: semaglutide injection format, storage, and request checklist.
Ozempic is an injectable semaglutide product listed in Japan for type 2 diabetes. This page helps international visitors identify the Japanese product wording, current 2 mg injection format, storage requirements, and the practical details support needs before follow-up.
Contact support with product detailsWhat “Ozempic in Japan” means
Here, “Japan” refers to the Japanese prescription-medicine information environment: Japanese brand wording, approved indication, package format, storage requirements, and the confirmation points support needs before any manual follow-up.
It does not mean this page decides whether Ozempic is medically suitable for you. Dose selection, treatment decisions, and switching from other GLP-1 medicines must be handled by a qualified healthcare professional.
Japanese name and product format
オゼンピック
The Japanese brand name for Ozempic.
皮下注
Subcutaneous injection. This distinguishes Ozempic from oral semaglutide tablets such as Rybelsus.
セマグルチド
Semaglutide, the active ingredient in Ozempic.
Format and availability points to confirm
Current Japanese medicine information lists Ozempic Subcutaneous Injection 2 mg. Older single-dose formats may still appear in online search results or old materials, so the exact Japanese listing and package format should be confirmed before any request.
| Item | How to write it in a request | What support checks |
|---|---|---|
| Current Japanese listing | Ozempic Subcutaneous Injection 2 mg / オゼンピック皮下注2mg | Current availability, manufacturer, package condition, and route feasibility. |
| Ingredient | Semaglutide / セマグルチド | Whether the request is for injectable semaglutide, not Rybelsus tablets or Wegovy. |
| Storage | Requires refrigerated handling before use; avoid freezing. | Cold-chain feasibility, destination country, route, delivery timing, and package protection. |
Medical information summary
Japanese product information identifies semaglutide as the active ingredient and classifies Ozempic as a sustained GLP-1 receptor agonist for type 2 diabetes mellitus. Japanese official information describes once-weekly subcutaneous use under medical direction.
MedGuide Japan does not provide diagnosis, dosing instructions, or treatment selection. Use prescription medicines only under qualified medical supervision and follow the rules of the destination country.
Ozempic vs Rybelsus vs Wegovy
| Product | Shared point | Key difference to avoid confusion |
|---|---|---|
| Ozempic | Semaglutide | Injectable GLP-1 product listed in Japan for type 2 diabetes. |
| Rybelsus | Semaglutide | Oral tablet. Administration timing and tablet count are central. |
| Wegovy | Semaglutide | Different Japanese product and indication context. Do not treat it as the same request. |
Safety points to mention before requesting
Tell your physician and support staff if any of the following are relevant:
- Type 1 diabetes, diabetic ketoacidosis, diabetic coma or precoma.
- Severe infection, surgery, or other urgent medical situation.
- History of pancreatitis or serious gastrointestinal disease.
- Pregnancy, breastfeeding, or planning pregnancy.
- Use of insulin, sulfonylureas, or other glucose-lowering medicines.
- Current or recent use of another semaglutide product, such as Rybelsus or Wegovy.
- Low food intake, heavy alcohol use, or strenuous physical exercise.
- Any previous allergy or serious reaction to semaglutide or injection products.
Cold-chain and shipping questions
Ozempic is an injection product with temperature-sensitive handling. A support request should not discuss only price or brand name. It should also include destination country, delivery route, expected signing time, seasonal temperature risk, and whether cold-chain packaging is practical.
Request checklist
- Exact product name: Ozempic Subcutaneous Injection 2 mg / オゼンピック皮下注2mg.
- Quantity or number of kits requested.
- Destination country or region.
- Whether you are using, continuing, or switching from another GLP-1 medicine.
- Whether the request is for continuing therapy or a new discussion with a clinician.
- Whether you are currently using Mounjaro, Rybelsus, Wegovy, insulin, or another glucose-lowering medicine.
- Any package photo, clinic instruction, or Japanese product listing you want support to check.
- Any medical history that could affect safety or shipment suitability.
Ozempic Japan FAQ
Is Ozempic Japan the same as semaglutide?
Ozempic is the brand name. Semaglutide is the active ingredient. A request should include both the product name and format.
Is Ozempic the same as Rybelsus?
No. Both contain semaglutide, but Ozempic is an injection and Rybelsus is a tablet with different administration rules.
Is Ozempic the same as Wegovy?
No. Both are semaglutide injections, but product names, strengths, and medical-use context differ. Use the exact Japanese listing.
Why does cold-chain handling matter?
Ozempic is an injectable medicine. Temperature exposure, route, and destination-country rules can affect whether support can proceed.
Can support choose my Ozempic dose?
No. Dose selection and treatment decisions must be handled by a qualified healthcare professional.
What should I send first?
Send the Japanese product name, quantity, destination country, cold-chain concern, and whether you are using other GLP-1 medicines.
Related GLP-1 pages
GLP-1 comparison guide
Compare Mounjaro, Ozempic, Wegovy, and Rybelsus in Japan.
Rybelsus Japan
Oral semaglutide tablet page for visitors comparing semaglutide products.
Contact checklist
Send product, quantity, destination country, cold-chain context, and GLP-1 use context.
Ask support with complete injection details.
Use the contact page to send the Ozempic product name, quantity, destination country, cold-chain context, and GLP-1 use context.
Contact supportMedGuide Japan provides product-information support only. We do not diagnose, choose doses, replace medical advice, or guarantee availability.